CURE is dedicated to conquering childhood cancer through funding targeted research while also supporting patients and their families. They believe that childhood cancer can be cured in our lifetime.
CURE offers research grants to further their mission, including the Translation to Cure (T2C) award and the Early Investigator (EI) award. These grants support targeted research efforts to conquer childhood cancer. The T2C award provides up to $330,000 over two years to cover direct and indirect costs, aiming to make significant advances in the fight against childhood cancer.